We use cookies on this site to enable your digital experience. By continuing to use this site, you are agreeing to our cookie policy. close

Federal Circuit Upholds Bench Trial Outcome In Drug Patent Dispute

Mealey's (September 7, 2018, 11:40 AM EDT) -- WASHINGTON, N.J. — A New Jersey federal judge’s determination that three patents relating to an extended release seizure medication are not invalid and would be infringed by a proposed generic drug...
To view the full article, register now.